Ground Swell Capital’s Amphastar Pharmaceuticals AMPH Stock Holding History

Ground Swell Capital’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$34K	Buy	+2,887	New	+$30.1K	0.06%	315

Other funds holding AMPH

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $143M AUM 102.52% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

KCM

Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Ground Swell Capital's AMPH Position: Q3 2014 in Review

Ground Swell Capital opened a new position in Amphastar Pharmaceuticals (AMPH) in Q3 2014: 2,887 shares worth $34K. The stake represents 0.06% of the portfolio and ranks #315 among its holdings.

45 funds tracked by Wall St. Rank hold AMPH as of Q3 2014.

Ground Swell Capital held 2,887 shares of Amphastar Pharmaceuticals worth $34K as of Q3 2014.
Amphastar Pharmaceuticals was a new Ground Swell Capital position in Q3 2014.
Amphastar Pharmaceuticals made up 0.06% of Ground Swell Capital's portfolio in Q3 2014, its #315 holding.
45 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2014.

Based on Ground Swell Capital's 13F filing for Q3 2014, filed 6 Nov 2014.